Related references
Note: Only part of the references are listed.Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities
Yankai Wen et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Synthetic mRNA-based differentiation method enables early detection of Parkinson's phenotypes in neurons derived from Gaucher disease-induced pluripotent stem cells
Tomohiko Akiyama et al.
STEM CELLS TRANSLATIONAL MEDICINE (2021)
Elevated glucosylsphingosine in Gaucher disease induced pluripotent stem cell neurons deregulates lysosomal compartment through mammalian target of rapamycin complex 1
Manasa P. Srikanth et al.
STEM CELLS TRANSLATIONAL MEDICINE (2021)
ROS in cancer therapy: the bright side of the moon
Bruno Perillo et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
A transcriptional and post-transcriptional dysregulation of Dishevelled 1 and 2 underlies the Wnt signaling impairment in type I Gaucher disease experimental models
Roberto Costa et al.
HUMAN MOLECULAR GENETICS (2020)
Interferon lambda promotes immune dysregulation and tissue inflammation in TLR7-induced lupus
Rishi R. Goel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Are Glucosylceramide-Related Sphingolipids Involved in the Increased Risk for Cancer in Gaucher Disease Patients? Review and Hypotheses
Patricia Dubot et al.
CANCERS (2020)
Effect of Substrate Reduction Therapy in Comparison to Enzyme Replacement Therapy on Immune Aspects and Bone Involvement in Gaucher Disease
Renuka P. Limgala et al.
BIOMOLECULES (2020)
The Human Gene Mutation Database (HGMD(R)): optimizing its use in a clinical diagnostic or research setting
Peter D. Stenson et al.
HUMAN GENETICS (2020)
Lyso-glycosphingolipids: presence and consequences
Marco van Eijk et al.
LIPID MEDIATORS (2020)
Mice defective in interferon signaling help distinguish between primary and secondary pathological pathways in a mouse model of neuronal forms of Gaucher disease
Ayelet Vardi et al.
JOURNAL OF NEUROINFLAMMATION (2020)
Complement C5a Induces Pro-inflammatory Microvesicle Shedding in Severely Injured Patients
Ebru Karasu et al.
FRONTIERS IN IMMUNOLOGY (2020)
Patients with Gaucher disease display systemic oxidative stress dependent on therapy status
Reena V. Kartha et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2020)
IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cells
Jaewoong Lee et al.
NATURE (2020)
Liver involvement in patients with Gaucher disease types I and III
Rodrigo Tzovenos Starosta et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2020)
Gaucher disease: single gene molecular characterization of one-hundred Indian patients reveals novel variants and the most prevalent mutation
Jayesh Sheth et al.
BMC MEDICAL GENETICS (2019)
Gene expression profile in patients with Gaucher disease indicates activation of inflammatory processes
Agnieszka Lugowska et al.
SCIENTIFIC REPORTS (2019)
β-Glycosphingolipids as Mediators of Both Inflammation and Immune Tolerance: A Manifestation of Randomness in Biological Systems
Yaron Ilan
FRONTIERS IN IMMUNOLOGY (2019)
Role of the complement system in the tumor microenvironment
Ronghua Zhang et al.
CANCER CELL INTERNATIONAL (2019)
Amphiregulin Regulates Phagocytosis-Induced Cell Death in Monocytes via EGFR and the Bcl-2 Protein Family
Christopher Platen et al.
MEDIATORS OF INFLAMMATION (2019)
IFITM3 directly engages and shuttles incoming virus particles to lysosomes
Jennifer S. Spence et al.
NATURE CHEMICAL BIOLOGY (2019)
Enhancement of cancer invasion and growth via the C5a-C5a receptor system: Implications for cancer promotion by autoimmune diseases and association with cervical cancer invasion
Masakazu Yoneda et al.
ONCOLOGY LETTERS (2019)
Database resources of the National Center for Biotechnology Information
Richa Agarwala et al.
NUCLEIC ACIDS RESEARCH (2018)
Hepatocellular carcinoma in Gaucher disease: an international case series
Martine Regenboog et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2018)
Complement C5a Fosters Squamous Carcinogenesis and Limits T Cell Response to Chemotherapy
Terry R. Medler et al.
CANCER CELL (2018)
Antigen-mediated regulation in monoclonal gammopathies and myeloma
Shiny Nair et al.
JCI INSIGHT (2018)
A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments
Jerome Stirnemann et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease
Manoj K. Pandey et al.
NATURE (2017)
Enhanced Wnt Signalling in Hepatocytes is Associated with Schistosoma japonicum Infection and Contributes to Liver Fibrosis
Qi Wang et al.
SCIENTIFIC REPORTS (2017)
Altered Differentiation Potential of Gaucher's Disease iPSC Neuronal Progenitors due to Wnt/β-Catenin Downregulation
Ola Awad et al.
STEM CELL REPORTS (2017)
Lysosomal storage and impaired autophagy lead to inflammasome activation in Gaucher macrophages
Elma Aflaki et al.
AGING CELL (2016)
Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma
Shiny Nair et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Neuronopathic Gaucher disease: dysregulated mRNAs and miRNAs in brain pathogenesis and effects of pharmacologic chaperone treatment in a mouse model
Nupur Dasgupta et al.
HUMAN MOLECULAR GENETICS (2015)
Emerging Functions of Amphiregulin in Orchestrating Immunity, Inflammation, and Tissue Repair
Dietmar M. W. Zaiss et al.
IMMUNITY (2015)
Activation of p38 Mitogen-Activated Protein Kinase in Gaucher's Disease
Kazuyuki Kitatani et al.
PLOS ONE (2015)
Massive parallel IGHV gene sequencing reveals a germinal center pathway in origins of human multiple myeloma
Graeme Cowan et al.
ONCOTARGET (2015)
Pharmacological Chaperones and Coenzyme Q10 Treatment Improves Mutant β-Glucocerebrosidase Activity and Mitochondrial Function in Neuronopathic Forms of Gaucher Disease
Mario de la Mata et al.
SCIENTIFIC REPORTS (2015)
Pathogenesis of Bone Alterations in Gaucher Disease: The Role of Immune System
Juan Marcos Mucci et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
MAPK and NF-κB Pathways Are Involved in Bisphenol A-Induced TNF-α and IL-6 Production in BV2 Microglial Cells
Jingying Zhu et al.
INFLAMMATION (2015)
The profibrotic role of endothelin-1: Is the door still open for the treatment of fibrotic diseases?
Fernando Rodriguez-Pascual et al.
LIFE SCIENCES (2014)
Overexpression of Endothelin 1 Triggers Hepatocarcinogenesis in Zebrafish and Promotes Cell Proliferation and Migration through the AKT Pathway
Jeng-Wei Lu et al.
PLOS ONE (2014)
Gaucher iPSC-Derived Macrophages Produce Elevated Levels of Inflammatory Mediators and Serve as a New Platform for Therapeutic Development
Leelamma M. Panicker et al.
STEM CELLS (2014)
Liver Fibrosis in Type I Gaucher Disease: Magnetic Resonance Imaging, Transient Elastography and Parameters of Iron Storage
Anneloes E. Bohte et al.
PLOS ONE (2013)
Induced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease
Leelamma M. Panicker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Synchronous presentation of Gaucher disease and solitary plasmacytoma with progression to multiple myeloma
M P H Hawkesford et al.
SCOTTISH MEDICAL JOURNAL (2011)
Tumor Necrosis Factor-a Signaling in Macrophages
Narayanan Parameswaran et al.
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2010)
The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients
Tamar H. Taddei et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Francesco Colotta et al.
CARCINOGENESIS (2009)
Spontaneous hepatic fibrosis in transgenic mice overexpressing PDGF-A
Florian Thieringer et al.
GENE (2008)
Altered intracellular redox status in Gaucher disease fibroblasts and impairment of adaptive response against oxidative stress
Marta Deganuto et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Oxidative stress and macrophage function: a failure to resolve the inflammatory response
P. Kirkham
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Increased incidence of cancer in adult Gaucher disease in Western Europe
M de Fost et al.
BLOOD CELLS MOLECULES AND DISEASES (2006)
Gaucher disease and cancer incidence: a study from the Gaucher Registry
BE Rosenbloom et al.
BLOOD (2005)
Inhibition of p38 mitogen-activated protein kinase ameliorates cytokine up-regulated shigatoxin-1 toxicity in human brain microvascular endothelial cells
PK Stricklett et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Massive hepatic fibrosis in Gaucher's disease: Clinicopathological and radiological features
RH Lachmann et al.
QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS (2000)
Share Paper
